Divergent estrogen receptor-positive and -negative breast cancer trends and etiologic heterogeneity in Denmark

International Journal of Cancer

Volumn 133, Issue 9, 2013, Pages 2201-2206

  Anderson, William F ^a   Rosenberg, Philip S ^a   Petito, Lucia ^a   Katki, Hormuzd A ^a   Ejlertsen, Bent ^b   Ewertz, Marianne ^c   Rasmussen, Birgitte B ^d   Jensen, Maj Britt ^b   Kroman, Niels ^e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Danish Breast Cancer Cooperative Group (DBCG) Registry   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^e Department of Breast Surgery ^*  (Denmark)

Author keywords

age period cohort models; breast cancer; epidemiology; estrogen receptor

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; DENMARK; DISEASE ASSOCIATION; ESTROGEN RECEPTOR NEGATIVE BREAST CANCER; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; GENETIC HETEROGENEITY; HUMAN; POSTMENOPAUSE; PREMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; TREND STUDY; TUMOR INVASION; UNITED STATES;

AGE-PERIOD-COHORT MODELS; BREAST CANCER; EPIDEMIOLOGY; ESTROGEN RECEPTOR;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DENMARK; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; PROGNOSIS; RECEPTORS, ESTROGEN; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 84882724687     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28222     Document Type: Article

References (31)

1. Desantis C, Howlader N, Cronin KA, et al. Breast cancer incidence rates in US women are no longer declining. Cancer Epidemiol Biomarkers Prev 2011; 20: 733-9.
2. Glass AG, Lacey JV, Jr, Carreon JD, et al. Breast cancer incidence, 1980 2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst 2007; 99: 1152-61.
3. Anderson WF, Katki HA, Rosenberg PS,. Breast cancer incidence in the United States: current and future trends. J Natl Cancer Inst 2011; 103: 1397-402.
4. Hammond ME, Hayes DF, Dowsett M, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 2010; 28: 2784-95.
5. Porter PL, El-Bastawissi AY, Mandelson MT, et al. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 1999; 91: 2020-8.
6. Tarone RE,. Breast cancer trends among young women in the United States. Epidemiology 2006; 17: 588-90.
7. F as in Fat: How obesity threatens America's future 2012. Robert Wood Johnson Foundation, 2012.
8. Lidegarrd O, Kroman N,. The epidemiology of breast cancer. Eur Clinics Obstet Gynaecol 2005; 1: 24-8.
9. Lassen TH, Sobotka T, Jensen TK, et al. Trends in rates of natural conceptions among Danish women born during 1960-1984. Hum Reprod 2012; 27: 2815-22.
10. Talman ML, Rasmussen BB, Andersen J, et al. Estrogen receptor analyses in the Danish Breast Cancer Cooperative Group. History, methods, prognosis and clinical implications. Acta Oncol 2008; 47: 789-94.
11. Vejborg I, Mikkelsen E, Garne JP, et al. Mammography screening in Denmark. Dan Med Bull 2011; 58: C4287.
12. Blichert-Toft M, Christiansen P, Mouridsen HT,. Danish Breast Cancer Cooperative Group-DBCG: history, organization, and status of scientific achievements at 30-year anniversary. Acta Oncol 2008; 47: 497-505.
13. Association of the Nordic Cancer Registries (NORDCAN). 2013. Available at: http://www-dep.iarc.fr/NORDCAN/english/table2.asp?cancer=180&period= 2010&period=2009&period=2008&period=2007&period=2006&period= 2005&period=2004&period=2003&period=2002&period=2001&period= 2000&period=1999&period=1998&period=1997&period=1996&period= 1995&period=1994&period=1993&sex=2&type=0&age-from= 7&age-to=17&sort=1®istry=1&submit=Execute (Accessed February 25, 2013).
14. Rostgaard K, Holst H, Mouridsen HT, et al. Do clinical databases render population-based cancer registers obsolete? The example of breast cancer in Denmark. Cancer Causes Control 2000; 11: 669-74.
15. Laenkholm AV, Knoop A, Ejlertsen B, et al. ESR1 gene status correlates with estrogen receptor protein levels measured by ligand binding assay and immunohistochemistry. Mol Oncol 2012; 6: 428-36.
16. Danish Breast Cancer Cooperative Group. 2012. Available at: http://www.dbcg.dk/ (Accessed September 1, 2012).
17. Olsen AH, Jensen A, Njor SH, et al. Breast cancer incidence after the start of mammography screening in Denmark. Br J Cancer 2003; 88: 362-5.
18. von Euler-Chelpin M, Olsen AH, Njor S, et al. Socio-demographic determinants of participation in mammography screening. Int J Cancer 2008; 122: 418-23.
19. Holford TR,. Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Public Health 1991; 12: 425-57.
20. Clayton D, Schifflers E,. Models for temporal variation in cancer rates. II. Age-period-cohort models. Stat Med 1987; 6: 469-81.
21. Mbulaiteye SM, Anderson WF, Ferlay J, et al. Pediatric, elderly, and emerging adult-onset peaks in Burkitt's lymphoma incidence diagnosed in four continents, excluding Africa. Am J Hematol 2012; 87: 573-8.
22. Anderson WF, Rosenberg PS, Menashe I, et al. Age-related crossover in breast cancer incidence rates between black and white ethnic groups. J Natl Cancer Inst 2008; 100: 1804-14.
23. Jemal A, Ma J, Rosenber PS, et al. Increasing lung cancer death rates among young women in southern and midwestern states. J Clin Oncol 2012; 30: 2739-44.
24. Anderson WF, Jatoi I, Sherman ME,. Qualitative age interactions in breast cancer studies: mind the gap. J Clin Oncol 2009; 27: 5308-11.
25. Bigaard J, Stahlberg C, Jensen M-B, et al. Breast cancer incidence by estrogen receptor status in Denmark from 1996 to 2007. Breast Cancer Res Treat 2012; 136: 559-64.
26. Sharpe KH, McClements P, Clark DI, et al. Reduced risk of oestrogen receptor positive breast cancer among peri- and post-menopausal women in Scotland following a striking decrease in use of hormone replacement therapy. Eur J Cancer 2010; 46: 937-43.
27. Lambe M, Hsieh C, Trichopoulos D, et al. Transient increase in the risk of breast cancer after giving birth. N Engl J Med 1994; 331: 5-9.
28. Colditz GA, Rosner BA, Chen WY, et al. Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst 2004; 96: 218-28.
29. Yang XR, Chang-Claude J, Goode EL, et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium Studies. J Natl Cancer Inst 2011; 103: 250-63.
30. Zhang X, Spiegelman D, Baglietto L, et al. Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies. Am J Clin Nutr 2012; 95: 713-25.
31. Bray F, Jemal A, Grey N, et al. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol 2012; 13: 790-801.